Corcept Therapeutics, Inc. (CORT)
51.35
-0.80
(-1.53%)
USD |
NASDAQ |
May 07, 10:42
Corcept Therapeutics Cash from Investing (Quarterly) : 4.542M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Merck & Co., Inc. | -10.21B |
| Integer Holdings Corp. | -37.90M |
| Stryker Corp. | -185.00M |
| Supernus Pharmaceuticals, Inc. | -19.22M |
| Terns Pharmaceuticals, Inc. | -350.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -16.77M |
| Cash from Financing (Quarterly) | 0.76M |
| Free Cash Flow | 119.79M |
| Free Cash Flow Per Share (Quarterly) | -0.1625 |
| Free Cash Flow to Equity (Quarterly) | -20.50M |
| Free Cash Flow to Firm (Quarterly) | -16.97M |
| Free Cash Flow Yield | 2.01% |